Results 11 to 20 of about 14,984 (246)
Medical student attitudes and perceptions of psychedelic-assisted therapies
Frontiers in Psychiatry, 2023 IntroductionAlthough certain psychedelic agents may soon gain federal approval for use in treating specific psychiatric conditions, the utilization of such therapies in clinical practice will depend largely on the attitudes of healthcare providers ...
Irene Li +5 more
doaj +1 more source
Psychedelics and Psychedelic-Assisted Psychotherapy
American Journal of Psychiatry, 2020 The authors provide an evidenced-based summary of the literature on the clinical application of psychedelic drugs in psychiatric disorders.Searches of PubMed and PsycINFO via Ovid were conducted for articles in English, in peer-reviewed journals, reporting on "psilocybin," "lysergic acid diethylamide," "LSD," "ayahuasca," "3,4 ...
Collin M, Reiff +7 more
openaire +4 more sources
Effects of classic psychedelic drugs on turbulent signatures in brain dynamics
Network Neuroscience, 2022 Psychedelic drugs show promise as safe and effective treatments for neuropsychiatric disorders, yet their mechanisms of action are not fully understood.
Josephine Cruzat +12 more
doaj +1 more source
The association between naturalistic use of psychedelics and co-occurring substance use disorders
Frontiers in Psychiatry, 2023 ObjectiveClassic psychedelics (LSD, psilocybin, and peyote/mescaline) have been used to support addiction treatment in a variety of contexts ranging from ceremonial use to clinical trials.
Jonina Rabinowitz +6 more
doaj +1 more source
Frontiers in Psychiatry, 2023 IntroductionPsychedelic-assisted therapy with psilocybin has shown promise in Phase 2 trials for alcohol use disorder (AUD). Set and setting, particularly factors facilitating a connection with nature, may positively influence the psychedelic experience ...
Keith G. Heinzerling +11 more
doaj +1 more source
Behavioral Psychedelics: Integrating Mind and Behavior to Improve Health and Resilience
Frontiers in Psychiatry, 2022 One of the most recent and potentially promising advancements in the health sciences has involved the attempted use of psychedelics for treating mental and behavioral health problems, such as anxiety, depression, posttraumatic stress disorder, and ...
Edmund C. Neuhaus +2 more
doaj +1 more source
Psychedelics Promote Structural and Functional Neural Plasticity. [PDF]
, 2018 Atrophy of neurons in the prefrontal cortex (PFC) plays a key role in the pathophysiology of depression and related disorders. The ability to promote both structural and functional plasticity in the PFC has been hypothesized to underlie the fast ...
Barragan, Eden V +15 more
core +2 more sources
Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action. [PDF]
Pharmacol Res PerspectABSTRACT Major Depressive Disorder (MDD) and chronic pain are independently debilitating conditions that frequently co‐occur. This comorbidity poses a significant clinical challenge, resulting in greater symptom severity, higher disability, and worse prognosis than either condition alone.
Kazdan J, Ladha KS, Husain MI.
europepmc +2 more sources
Classic psychedelics do not affect T cell and monocyte immune responses
Frontiers in Psychiatry, 2023 IntroductionClassic psychedelics have been shown to exert therapeutic potential for the treatment of various psychiatric disorders, neuropsychiatric diseases, and neuronal damage.
Deborah Rudin +5 more
doaj +1 more source
Self unbound: ego dissolution in psychedelic experience [PDF]
, 2017 Users of psychedelic drugs often report that their sense of being a self or ‘I’ distinct from the rest of the world has diminished or altogether dissolved.
Gerrans, Philip, Letheby, Chris
core +2 more sources